Not logged in.png)
Share.png)
SaveSimultaneous Head and Neck and Lung Cancers: Implications and Therapeutic Management Timing
Ebode, Dario; Truong, France; Halimi, Caroline; Dupont, Axelle; Gounant, Valerie; Faivre, Sandrine; Hourseau, Muriel; Barry, Beatrix; Brenet, Esteban; Evrard, Diane Share Save Strategies for early detection and detailed characterization of oral lesions and head and neck squamous cell carcinoma in Fanconi anemia patientsBeddok, Arnaud; Velleuer, Eunike; Fontbrune, Flore Sicre de; Brakenhoff, Ruud H.; Dalle, Jean-Hugues; Dufour, Carlo; Faivre, Sandrine; Genet, Carine; Klijanienko, Jerzy; Krieg, Christine; Leblanc, Thierry; Martinez, Pierre; Latour, Regis Peffault de; Rigolet, Arnaud; Saintigny, Pierre; Lyonnet, Dominique Stoppa; Soulier, Jean; Surralles, Jordi; Schramm, Martin; Thariat, Juliette Share Save Buparlisib and Paclitaxel in Patients with Head and Neck Squamous Cell Carcinoma: Immunogenomic Biomarkers of Efficacy from the BERIL-1 StudyDesilets, Antoine; Lucas, Justin; Licitra, Lisa F.; Lu, Sunny; Tse, Archie; Tang, Tom; Dreyer, Kevin; He, Nanhai; Birgerson, Lars E.; Faivre, Sandrine; Soulieres, Denis Share Save The MUSES*: a prognostic study on 1360 patients with sinonasal cancer undergoing endoscopic surgery-based treatment * MUlti-institutional collaborative Study on Endoscopically treated Sinonasal cancersFerrari, Marco; Mattavelli, Davide; Tomasoni, Michele; Raffetti, Elena; Bossi, Paolo; Schreiber, Alberto; Orlandi, Ester; Taboni, Stefano; Rampinelli, Vittorio; Gualtieri, Tommaso; Turri-Zanoni, Mario; Battaglia, Paolo; Arosio, Alberto D.; Bignami, Maurizio; Tartaro, Tiziana; Molteni, Marinella; Bertazzoni, Giacomo; Fiaux-Camous, Domitille; Jourdaine, Clement; Verillaud, Benjamin; Eu, Donovan; Nair, Deepa; Moiyadi, Aliasgar; Shetty, Prakash; Ghosh-Laskar, Sarbani; Budrukkar, Ashwini; Magrini, Stefano M.; Guillerm, Sophie; Faivre, Sandrine; Piazza, Cesare; Gilbert, Ralph W.; Irish, Jonathan C.; de Almeida, John R.; Pai, Prathamesh; Herman, Philippe; Castelnuovo, Paolo; Nicolai, Piero Share Save Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression (Apr, 10.1038/s41416-021-01334-9, 2021)Decaens, Thomas; Barone, Carlo; Assenat, Eric; Wermke, Martin; Fasolo, Angelica; Merle, Philippe; Blanc, Jean-Frederic; Grando, Veronique; Iacobellis, Angelo; Villa, Erica; Trojan, Joerg; Straub, Josef; Bruns, Rolf; Berghoff, Karin; Scheele, Juergen; Raymond, Eric; Faivre, Sandrine Share Save Phase 1b/2 trial of tepotinib in sorafenibpretreated advanced hepatocellular carcinoma with MET overexpressionDecaens, Thomas; Barone, Carlo; Assenat, Eric; Wermke, Martin; Fasolo, Angelica; Merle, Philippe; Blanc, Jean-Frederic; Grando, Veronique; Iacobellis, Angelo; Villa, Erica; Trojan, Joerg; Straub, Josef; Bruns, Rolf; Berghoff, Karin; Scheele, Juergen; Raymond, Eric; Faivre, Sandrine Share Save Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation TrialLebbe, Celeste; Italiano, Antoine; Houede, Nadine; Awada, Ahmad; Aftimos, Philippe; Lesimple, Thierry; Dinulescu, Monica; Schellens, Jan H. M.; Leijen, Suzanne; Rottey, Sylvie; Kruse, Vibeke; Kefford, Richard; Raymond, Eric; Faivre, Sandrine; Pages, Celine; Gomez-Roca, Carlos; Schueler, Armin; Goodstal, Samantha; Massimini, Giorgio; Delord, Jean-Pierre Share Save Share Save Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid TumorsDelord, Jean-Pierre; Italiano, Antoine; Awada, Ahmad; Aftimos, Philippe; Houede, Nadine; Lebbe, Celeste; Pages, Celine; Lesimple, Thierry; Dinulescu, Monica; Schellens, Jan H. M.; Leijen, Suzanne; Rottey, Sylvie; Kruse, Vibeke; Kefford, Richard; Faivre, Sandrine; Gomez-Roca, Carlos; Scheuler, Armin; Massimini, Giorgio; Raymond, Eric Share Save Diet-variants and immune characterization of a stage-defined, transgenic immunocompetent mouse model of HCC (ASV-B)Tijeras-Raballand, Annemilai; Hobeika, Christian; Bonnin, Philippe; Rousseau, Benoit; Rodrigues, Aurelie; Ladfil, Fouad; Pocard, Marc; de Gramont, Armand; Raymond, Eric; Faivre, Sandrine; Paradis, Valerie; Eveno, Clarisse Share Save Share Save Share Save First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular CarcinomaKim, Richard D.; Sarker, Debashis; Meyer, Tim; Yau, Thomas; Macarulla, Teresa; Park, Joong-Won; Choo, Su Pin; Hollebecque, Antoine; Sung, Max W.; Lim, Ho-Yeong; Mazzaferro, Vincenzo; Trojan, Joerg; Zhu, Andrew X.; Yoon, Jung-Hwan; Sharma, Sunil; Lin, Zhong-Zhe; Chan, Stephen L.; Faivre, Sandrine; Feun, Lynn G.; Yen, Chia-Jui; Dufour, Jean-Francois; Palmer, Daniel H.; Llovet, Josep M.; Manoogian, Melissa; Tugnait, Meera; Stransky, Nicolas; Hagel, Margit; Kohl, Nancy E.; Lengauer, Christoph; Sherwin, Cori Ann; Schmidt-Kittler, Oleg; Hoeflich, Klaus P.; Shi, Hongliang; Wolf, Beni B.; Kang, Yoon-Koo Share Save Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in FranceMoya-Plana, A.; Auperin, A.; Obongo, R.; Baglin, A.; Ferrand, F. R.; Baujat, B.; Saroul, N.; Casiraghi, O.; Vergez, S.; Herman, P.; Janot, F.; Thariat, J.; Verillaud, B.; de Gabory, L.; Albert, S.; Andry, G.; Babin, E.; Bach, C.; Badet, J. -M.; Badoual, C.; Baglin, A. C.; Banal, A.; Barry, B.; Baudin, E.; Baujat, B.; Bensadoun, R. J.; Bertolus, C.; Bessede, J. -P.; Blanchard, D.; Borel, C.; Bozorg-Grayeli, A.; Breheret, R.; Breton, P.; Brugel, L.; Calais, G.; Casiraghi, O.; Cassagnau, E.; Castillo, L.; Ceruse, P.; Chabolle, F.; Chevalier, D.; Chobaut, J. C.; Choussy, O.; Cosmidis, A.; Coste, A.; Costes, V.; Crampette, L.; Darrouzet, V.; Demez, P.; Dessi, P.; Devauchelle, B.; Digue, L.; Dolivet, G.; Dubrulle, F.; Duflo, S.; Dufour, X.; Even, C.; Faivre, S.; Fakhry, N.; Ferron, C.; Floret, F.; de Gabory, L.; Garrel, R.; Geoffrois, L.; Gilain, L.; Giovanni, A.; Girod, A.; Guerrier, B.; Hans, S.; Herman, P.; Hofman, P.; Housset, M.; Jankowski, R.; Jegoux, F.; Julieron, M.; Kaminsky, M. -C.; Kolb, F.; St Guily, J. Lacau; Laccoureye, L.; Lallemant, B.; Lang, P.; Lartigau, E.; Lavieille, J. -P.; Lefevre, M.; Leroy, X.; Malard, O.; Massip, F.; Mauvais, O.; Merol, J. -C.; Michel, J.; Mom, T.; Moriniere, S.; de Mones, E.; Moulin, G.; Moya-Plana, A.; Noel, G.; Poissonnet, G.; Prades, J. -M.; de Raucourt, D.; Reyt, E.; Righini, C.; Robin, Y. Marie; Rolland, F.; Ruhin, B.; Sarroul, N.; Schultz, P.; Serrano, E.; Sterkers, O.; Strunski, V.; Sudaka, A.; Tassart, M.; Testelin, S.; Thariat, J.; Timochenko, A.; Toussaint, B.; Coste, E. Uro; Valette, G.; Van den Abbeele, T.; Varoquaux, A.; Veillon, F.; Vergez, S.; Verillaud, B.; Wassef, M. Share Save Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular CarcinomaNault, Jean-Charles; Martin, Yoann; Caruso, Stefano; Hirsch, Theo Z.; Bayard, Quentin; Calderaro, Julien; Charpy, Cecile; Copie-Bergman, Christiane; Ziol, Marianne; Bioulac-Sage, Paulette; Couchy, Gabrielle; Blanc, Jean-Frederic; Nahon, Pierre; Amaddeo, Giuliana; Ganne-Carrie, Nathalie; Morcrette, Guillaume; Chiche, Laurence; Duvoux, Christophe; Faivre, Sandrine; Laurent, Alexis; Imbeaud, Sandrine; Rebouissou, Sandra; Llovet, Josep M.; Seror, Olivier; Letouze, Eric; Zucman-Rossi, Jessica Share Save A Phase 2 Study of Galunisertib (TGF-β1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular CarcinomaKelley, R. K.; Gane, E.; Assenat, E.; Siebler, J.; Galle, P. R.; Merle, P.; Hourmand, I. O.; Cleverly, A.; Zhao, Y.; Gueorguieva, I; Lahn, M.; Faivre, S.; Benhadji, K. A.; Giannelli, G. Share Save Share Save Share Save Diet-variants and immune characterization of a stage-defined, transgenic immunocompetent mouse model of HCC (ASV-B)Tijeras-Raballandi, Annemile; Hobeika, Christian; Rousseau, Benoit; Hainaud, Patricia; Bonnin, Philippe; Rodriguess, Aurelia; Ladfil, Fouad; Pocard, Marc; Paradis, Valerie; de Gramonti, Armand; Raymond, Eric; Dupuy, Evelyne; Eveno, Clarisse; Faivre, Sandrine Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
